Actidose Aqua Suspension
NDC Package 0574-0521-76
Package Information
Actidose Aqua (activated charcoal) suspension is •Shake well.•Unscrew cap and remove foil. This formulation utilizes a suspension delivery system. Marketed by Padagis Us Llc, this product is identified by NDC 0574-0521 and is authorized under FDA application M023.
Identification & Billing
- RxCUI: 1251411 - ACTIDOSE 208 MG/mL Oral Suspension
- RxCUI: 1251411 - activated charcoal 208 MG/ML Oral Suspension [Actidose]
- RxCUI: 1251411 - Actidose 15 GM per 72 ML Oral Suspension
- RxCUI: 1251411 - Actidose 208 MG/ML Oral Suspension
- RxCUI: 1251411 - Actidose 25 GM per 120 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0574 - Padagis Us Llc
- 0574-0521 - Actidose Aqua
- 0574-0521-76 - 240 mL in 1 TUBE
- 0574-0521 - Actidose Aqua
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0574-0521). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0574-0521-76 identifies a specific commercial package of 240 ml in 1 tube of Actidose Aqua, a human over the counter drug labeled by Padagis Us Llc. This product is billed per "ML" milliliter and contains an estimated amount of 240 billable units per package. This suspension is formulated for oral use and contains activated charcoal as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Us Llc on November 10, 2020. The current certification is valid through December 31, 2027.
How is this Padagis Us Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00574052176. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 240 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.